Chinese Herbal Medicine Combined with Entecavir for HBeAg Positive Chronic Hepatitis B: Study Protocol for a Multi-Center, Double-Blind Randomized-Controlled Trial-Reference-Cited by-同舟云学术

Chinese Herbal Medicine Combined with Entecavir for HBeAg Positive Chronic Hepatitis B: Study Protocol for a Multi-Center, Double-Blind Randomized-Controlled Trial

Published:2018-09 Issue:9 Volume:24 Page:653-660
ISSN:1672-0415
Container-title:Chinese Journal of Integrative Medicine
language:en
Short-container-title:Chin. J. Integr. Med.

Author:

Ye Yong-an,Li Xiao-ke,Zhou Da-qiao,Chi Xiao-ling,Li Qin,Wang Li,Lu Bing-jiu,Mao De-wen,Wu Qi-kai,Wang Xian-bo,Zhang Ming-xiang,Xue Jing-dong,Li Yong,Lu Wei,Guo Jian-chun,Jiang Feng,Zhang Xin-wei,Du Hong-bo,Yang Xian-zhao,Guo Hui,Gan Da-nan,Li Zhi-guo

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Complementary and alternative medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11655-018-3011-5.pdf

Reference53 articles.

1. Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age–specific HBsAg seroprevalence and endemicity. Vaccine 2012;30:2212–2219.

2. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004;11:97–107.

3. Lu FM, Zhuang H. Management of hepatitis B in China. Chin Med J 2009,122:3–4.

4. Liaw Y, Kao J, Piratvisuth T, Chan HLY, Chien R, Liu C, et al. Asian–Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. Hepatol Int 2012;6:531–561.

5. Baran B. Nucleos(t)ide analogs in the prevention of hepatitis B virus related hepatocellular carcinoma. World J Hepatol 2015;7:1742.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the mechanism of JiGuCao capsule formula on treating hepatitis B virus infection via network pharmacology analysis and in vivo/vitro experiment verification;Frontiers in Pharmacology;2023-06-08

2. Systematic analysis on the mechanism of Zhizi-Bopi decoction against hepatitis B via network pharmacology and molecular docking;Biotechnology Letters;2023-02-18

3. The mechanism of TiaoGanYiPi formula for treating chronic hepatitis B by network pharmacology and molecular docking verification;Scientific Reports;2021-04-16

4. Entecavir combining Chinese herbal medicine for HBeAg-positive chronic hepatitis B patients: a randomized, controlled trial;Hepatology International;2020-10-30

5. Chinese herbal medicine combined with entecavir to reduce the off-therapy recurrence risk in HBeAg-positive chronic hepatitis B patients: a multi-center, double-blind, randomized controlled trial in China;Trials;2020-08-12